Results 51 to 60 of about 28,971 (170)

Looking towards the future: patient-specific computational modeling to optimize outcomes for transcatheter mitral valve repair

Frontiers in Cardiovascular Medicine, 2023
Severe mitral valve regurgitation (MR) is a heart valve disease that progresses to end-stage congestive heart failure and death if left untreated. Surgical repair or replacement of the mitral valve (MV) remains the gold standard for treatment of severe ...
Paul Wong, A. Wisneski, A. Sandhu, Zhongjie Wang, V. Mahadevan, Tom C. Nguyen, J. Guccione   +6 more
semanticscholar   +1 more source

Mitral Regurgitation International Database (MIDA) Score Predicts Outcome in Patients With Heart Failure Undergoing Transcatheter Edge‐to‐Edge Mitral Valve Repair

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Optimizing risk stratification in patients undergoing transcatheter mitral valve repair is an ongoing challenge. The Mitral Regurgitation International Database (MIDA) score represents a user‐friendly mortality risk stratification tool that is
Refik Kavsur, Maximilian Spieker, Christos Iliadis, Clemens Metze, Moritz Transier, Vedat Tiyerili, Patrick Horn, Stephan Baldus, Malte Kelm, Georg Nickenig, Ralf Westenfeld, Roman Pfister, Marc Ulrich Becher   +12 more
doaj   +1 more source

Transcatheter mitral valve repair/replacement for primary mitral regurgitation [PDF]

Annals of Cardiothoracic Surgery, 2018
This review outlines the first trial experience with transcatheter therapy for mitral regurgitation (MR), developed from the EVEREST II MitraClip trial in a trial population comprised predominantly of patients with degenerative mitral regurgitation (DMR).
Ted, Feldman, Eugene, Fernandes, Justin P, Levisay   +2 more
openaire   +2 more sources

Challenges and Open Issues in Transcatheter Mitral Valve Implantation: Smooth Seas Do Not Make Skillful Sailors

Frontiers in Cardiovascular Medicine, 2022
According to the European and American guidelines, surgery represents the treatment of choice for mitral valve (MV) disease. However, a number of patients are deemed unsuitable for surgery due to a prohibitive/high operative risk.
Giulio Russo, Giulio Russo, Francesco Maisano, Gianluca Massaro, Giuseppe Terlizzese, Enrica Mariano, Michela Bonanni, Andrea Matteucci, Andrea Bezzeccheri, Daniela Benedetto, Gaetano Chiricolo, Eugenio Martuscelli, Giuseppe Massimo Sangiorgi   +12 more
doaj   +1 more source

Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair: A Multicenter Experience.

JACC: Cardiovascular Interventions
BACKGROUND Management of recurrent mitral regurgitation (MR) or relevant iatrogenic mitral valve (MV) stenosis after mitral transcatheter edge-to-edge repair (M-TEER) emerges as an increasingly relevant clinical issue.
D. Samim, P. Sorajja, J. Lanz, L. Stolz, D. Angellotti, J. Hausleiter, H. Ruge, E. Kuhn, S. Baldus, L. Ochs, Hiroki A. Ueyama, V. Babaliaros, Adam B. Greenbaum, M. Gössl, Jaroslav Januska, Mohammad Alreshidan, D. Reineke, Stephan Windecker, M. Adam, F. Praz   +19 more
semanticscholar   +1 more source

Minimally invasive mitral valve surgery after failed transcatheter mitral valve repair in an intermediate-risk cohort

Interactive Cardiovascular and Thoracic Surgery, 2022
OBJECTIVES Although clinical experience with transcatheter mitral valve interventions is rapidly increasing, there is still a lack of evidence regarding surgical treatment options for the management of recurrent mitral regurgitation (MR).
S. Akansel, Markus Kofler, K. V. Van Praet, A. Unbehaun, S. Sündermann, S. Jacobs, V. Falk, J. Kempfert   +7 more
semanticscholar   +1 more source

Acute Reduction in Left Ventricular Function Following Transcatheter Mitral Edge‐to‐Edge Repair

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Little is known about the impact of transcatheter mitral valve edge‐to‐edge repair on changes in left ventricular ejection fraction (LVEF) and the effect of an acute reduction in LVEF on prognosis.
Leor Perl, Mark Kheifets, Ascione Guido, Eustachio Agricola, Paolo Denti, Mirjam Gauri Wild, Fabien Praz, Antonio Popolo Rubbio, Francesco Bedogni, Federico De Marco, Ronen Beeri, Mony Shuvy, Francesco Melillo, Matteo Montorfano, Xavier Freixa, Juan Carlos de la Fuente Mancera, Arturo Giordano, Filippo Finizio, Nicolas M. Van Mieghem, J. F. W. Ooms, Neil Fam, Cormac O'Connor, Stefan Toggweiler, Amos Levi, Yaron Shapira, Shmuel Schwartzenberg, Stefano Pidello, Fabrizio D'Ascenzo, Filippo Angelini, Dan Haberman, Gabriele Crimi, Italo Porto, Ottavia Cozzi, Francesco Giannini, Giuseppe Tarantini, Francesco Maisano, Ran Kornowski   +36 more
doaj   +1 more source

Predictors of Residual Severe Tricuspid Regurgitation After Transcatheter Mitral Valve Repair

Journal of the Society for Cardiovascular Angiography & Interventions, 2023
Background Severe tricuspid regurgitation (TR) may persist after a mitral transcatheter edge-to-edge repair (M-TEER) and is associated with worsened clinical outcomes and survival.
C. Basman, Arber Kodra, L. Pirelli, Ahmad Mustafa, P. Mehla, B. Trost, Caroline Ong, Taylor Remillard, Emily Schultz, Denny Wang, Shangyi Liu, Efstathia A. Mihelis, B. Rutkin, E. Koss, R. Kalimi, Gregory A. Maniatis, A. Supariwala, S. Scheinerman, C. Kliger   +18 more
semanticscholar   +1 more source

Technologies in minimally invasive treatment of severe mitral regurgitation

Cardiology Journal
Mitral valve regurgitation is the second most common valve defect in Europe among adults. Primary mitral regurgitation (MR) results from structural abnormalities of the valve apparatus (e.g., leaflet prolapse, chordae rupture), often due to myxomatous ...
Magdalena Synak, Marta Mazur, Kamil Marzec, Krzysztof Sanetra, Justyna Jankowska-Sanetra, Piotr P. Buszman, Paweł Kaźmierczak, Krzysztof Milewski, Witold Gerber   +8 more
doaj   +1 more source

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Valve Repair (OneForAll‐Registry)

Catheterization and cardiovascular interventions
Mitral valve transcatheter edge‐to‐edge repair (M‐TEER) is increasingly applied in patients with high surgical risk. We aimed to evaluate whether the PASCAL system can be applied in an all‐comers cohort irrespective of the underlying anatomy and whether ...
K. Hellhammer, F. Schindhelm, Matthias Riebisch, R. Jánosi, A. Lind, M. Totzeck, P. Luedike, T. Rassaf, A. Mahabadi   +8 more
semanticscholar   +1 more source